Gilead Sciences, Inc. (GILD) Presents At Cantor Global Healthcare Conference 2025 Transcript

Group 1 - The new Chief Medical Officer has had a positive initial experience in the first two months at the company, highlighting the depth of science and quality of the team as impressive aspects [2] - The transition into the new role involved a learning curve, with the CMO acknowledging the importance of diligence on the portfolio prior to joining [2] - The company has demonstrated a strong team dynamic and scientific expertise, which were pleasantly surprising to the new executive [2]